Need Help?

Dataset GBM 2022

The cellular origin and differentiation status of glioblastoma by scRNA-seq

Request Access

policy_GBM2022

1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify THIS TEAM IN KAROLINSKA INS. within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify THIS TEAM IN KAROLINSKA INS. prior to any significant changes to the protocol for the Project. 14. The User Institution will notify THIS TEAM IN KAROLINSKA INS. as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. THIS TEAM IN KAROLINSKA INS. may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than THIS TEAM IN KAROLINSKA INS.. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00006158531 1651616761071 925.8 MB
EGAF00006158532 1651616640478 704.9 MB
EGAF00006158533 1651617540543 1.0 GB
EGAF00006158534 1651617165926 852.2 MB
EGAF00006158535 1651616700840 986.9 MB
EGAF00006158536 1651617020041 431.5 MB
EGAF00006158537 1651617326257 812.7 MB
EGAF00006158538 1651616522261 537.5 MB
EGAF00006158539 1651624680288 1.5 GB
EGAF00006158540 1651617165926 1.1 GB
EGAF00006158541 1651622749692 2.4 GB
EGAF00006158542 1651617605617 1.2 GB
EGAF00006158543 1651617605617 912.1 MB
EGAF00006158544 1651616761071 497.3 MB
EGAF00006158545 1651620855810 1.4 GB
EGAF00006158546 1651617165926 637.7 MB
EGAF00006158547 1651619135040 1.1 GB
EGAF00006158548 1651617855553 811.9 MB
EGAF00006158549 1651617688788 1.0 GB
EGAF00006158550 1651617688788 960.1 MB
EGAF00006158551 1651617924347 790.0 MB
EGAF00006158552 1651617493627 761.7 MB
EGAF00006158553 1651619189902 1.4 GB
EGAF00006158554 1651621332860 1.6 GB
EGAF00006158555 1651620060353 1.4 GB
EGAF00006158556 1651622884968 1.6 GB
EGAF00006158557 1651617165926 572.5 MB
EGAF00006158558 1651619953371 1.4 GB
EGAF00006158559 1651621854393 1.7 GB
EGAF00006158560 1651617976551 798.6 MB
EGAF00006158561 1651617780349 1.0 GB
EGAF00006158562 1651617855553 960.7 MB
EGAF00006158563 1651620770603 1.5 GB
EGAF00006158564 1651618620780 1.1 GB
EGAF00006158565 1651618514611 880.3 MB
EGAF00006158566 1651618440372 679.5 MB
EGAF00006158567 1651618020353 1.2 GB
EGAF00006158568 1651618265401 1.2 GB
EGAF00006158569 1651617976551 856.7 MB
EGAF00006158570 1651617924347 392.7 MB
EGAF00006158571 1651621565829 1.5 GB
EGAF00006158572 1651618387721 1.1 GB
EGAF00006158573 1651618779169 914.2 MB
EGAF00006158574 1651619520261 845.3 MB
EGAF00006158575 1651618152570 747.0 MB
EGAF00006158576 1651621500434 1.7 GB
EGAF00006158577 1651623097061 2.0 GB
EGAF00006158578 1651619017111 912.1 MB
EGAF00006158579 1651619189902 786.4 MB
EGAF00006158580 1651617855553 946.0 MB
EGAF00006158581 1651618387721 1.2 GB
EGAF00006158582 1651618779169 977.8 MB
EGAF00006158583 1651618320528 980.6 MB
EGAF00006158584 1651622280924 2.2 GB
EGAF00006158585 1651619135040 1.1 GB
EGAF00006158586 1651618779169 794.8 MB
EGAF00006158587 1651618387721 876.6 MB
EGAF00006158588 1651620491793 1.4 GB
EGAF00006158589 1651621620473 1.6 GB
EGAF00006158590 1651620420907 1.0 GB
EGAF00006158591 1651618779169 1.1 GB
EGAF00006158592 1651618562600 745.1 MB
EGAF00006158593 1651619254344 778.0 MB
EGAF00006158594 1651619756049 1.0 GB
EGAF00006158595 1651619135040 1.0 GB
EGAF00006158596 1651619017111 912.1 MB
EGAF00006158597 1651619485798 787.3 MB
EGAF00006158598 1651618514611 716.2 MB
EGAF00006158599 1651619348660 577.6 MB
EGAF00006158600 1651618779169 692.3 MB
EGAF00006158601 1651619756049 1.1 GB
EGAF00006158602 1651618562600 658.8 MB
EGAF00006158603 1651618680469 482.0 MB
EGAF00006158604 1651619017111 833.3 MB
EGAF00006158605 1651620300424 1.4 GB
EGAF00006158606 1651620060353 805.7 MB
EGAF00006158607 1651620592506 1.1 GB
EGAF00006158608 1651620592506 877.4 MB
EGAF00006158609 1651619485798 1.2 GB
EGAF00006158610 1651624860369 2.9 GB
80 Files (84.6 GB)